News & Updates
Showing Paediatrics articles
Showing
Show Multimedia Only

JAK inhibitor a new hope for new-onset T1D?
02 Oct 2025
byAudrey Abella
The 2-year outcomes from the phase II BANDIT* trial confirm the potential of the Janus kinase (JAK) inhibitor baricitinib for the treatment of new-onset type 1 diabetes (T1D).
JAK inhibitor a new hope for new-onset T1D?
02 Oct 2025
Balancing hope and healing in managing gynaecological tumours in children and adolescents
02 Oct 2025
bySaras Ramiya
Gynaecological tumours such as ovarian tumours in children and adolescents present complex diagnostic, emotional, and treatment challenges for young patients, families, and healthcare providers.







